Spyre Therapeutics, Inc. (SYRE)
41.04
-1.45
(-3.41%)
USD |
NASDAQ |
Mar 03, 14:08
Spyre Therapeutics Total Liabilities (Quarterly) : 62.54M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Tyra Biosciences, Inc. | 21.34M |
| PTC Therapeutics, Inc. | 3.117B |
| Agios Pharmaceuticals, Inc. | 104.11M |
| Tandem Diabetes Care, Inc. | 725.94M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 777.78M |
| Shareholders Equity (Quarterly) | 715.24M |
| Current Ratio | 13.25 |